These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 1772596)

  • 1. Equine cutaneous amyloidosis derived from an immunoglobulin lambda-light chain. Immunohistochemical, immunochemical and chemical results.
    Linke RP; Geisel O; Mann K
    Biol Chem Hoppe Seyler; 1991 Sep; 372(9):835-43. PubMed ID: 1772596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of lambda light chain amyloid in eight canine and two feline extramedullary plasmacytomas.
    Platz SJ; Breuer W; Geisel O; Linke RP; Hermanns W
    J Comp Pathol; 1997 Jan; 116(1):45-54. PubMed ID: 9076599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of an amyloid fibril protein from localized amyloidosis of the skin as lambda immunoglobulin light chains of variable subgroup I (A lambda I).
    Husby G; Sletten K; Blumenkrantz N; Danielsen L
    Clin Exp Immunol; 1981 Jul; 45(1):90-6. PubMed ID: 6796317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin lambda-light-chain-derived amyloidosis (A lambda) in two horses.
    Linke RP; Trautwein G
    Blut; 1989 Mar; 58(3):129-32. PubMed ID: 2495038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial amino acid sequence of an amyloid fibril protein from nodular primary cutaneous amyloidosis showing homology to lambda immunoglobulin light chain of variable subgroup III (a lambda III).
    Kitajima Y; Hirata H; Kagawa Y; Yaoita H
    J Invest Dermatol; 1990 Sep; 95(3):301-3. PubMed ID: 2117035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid fibrils derived from V-region together with C-region fragments from a lambda II-immunoglobulin light chain (HAR).
    Eulitz M; Linke R
    Biol Chem Hoppe Seyler; 1985 Sep; 366(9):907-15. PubMed ID: 3935132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of amyloid deposits and P component from a patient with factor X deficiency reveals proteins derived from a lambda VI light chain.
    Cohen D; Pras M; Franklin EC; Frangione B
    Am J Med; 1983 Mar; 74(3):513-8. PubMed ID: 6402931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary localized amyloidosis of the eyelid: two cases of immunoglobulin light chain-derived proteins, subtype lambda V respectively lambda VI.
    Olsen KE; Sandgren O; Sletten K; Westermark P
    Clin Exp Immunol; 1996 Nov; 106(2):362-6. PubMed ID: 8918586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coexistence of protein AA and immunoglobulin light-chain fragments in amyloid fibrils.
    Westermark P; Natvig JB; Anders RF; Sletten K; Husby G
    Scand J Immunol; 1976; 5(1-2):31-6. PubMed ID: 57640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoglobulin heavy-chain-associated amyloidosis.
    Eulitz M; Weiss DT; Solomon A
    Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6542-6. PubMed ID: 2118650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A chemical classification of amyloid. Correlation with different clinical types of amyloidosis.
    Husby G
    Scand J Rheumatol; 1980; 9(1):60-4. PubMed ID: 6769151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation of immunoglobulin light chain amyloid oligomers in primary cutaneous nodular amyloidosis.
    Clos AL; Lasagna-Reeves CA; Castillo-Carranza DL; Sengupta U; Jackson GR; Kelly B; Beachkofsky TM; Kayed R
    Br J Dermatol; 2011 Dec; 165(6):1349-54. PubMed ID: 21729025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain-restricted amyloidoma of immunoglobulin lambda-light chain origin clinically resembling multiple sclerosis.
    Linke RP; Gerhard L; Lottspeich F
    Biol Chem Hoppe Seyler; 1992 Dec; 373(12):1201-9. PubMed ID: 1292505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The amino-acid sequence of the variable region of a carbohydrate-containing amyloid fibril protein EPS (immunoglobulin light chain, type lambda).
    Toft KG; Sletten K; Husby G
    Biol Chem Hoppe Seyler; 1985 Jul; 366(7):617-25. PubMed ID: 3929803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of immunoglobulins in amyloidogenesis in cutaneous nodular amyloidosis.
    Ito K; Hashimoto K; Kambe N; Van S
    J Invest Dermatol; 1987 Oct; 89(4):415-8. PubMed ID: 3117902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid fibril protein related to immunoglobulin lambda-chains.
    Skinner M; Benson MD; Cohen AS
    J Immunol; 1975 Apr; 114(4):1433-5. PubMed ID: 804011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced glycation end product-modified beta2-microglobulin is a component of amyloid fibrils of primary localized cutaneous nodular amyloidosis.
    Fujimoto N; Yajima M; Ohnishi Y; Tajima S; Ishibashi A; Hata Y; Enomoto U; Konohana I; Wachi H; Seyama Y
    J Invest Dermatol; 2002 Mar; 118(3):479-84. PubMed ID: 11874487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical and immunochemical study of amyloid in liver affected by systemic Alambda amyloidosis with antibodies against three different regions of immunoglobulin lambda light chain.
    Kiyama M; Hoshii Y; Cui D; Kawano H; Kanda T; Ishihara T
    Pathol Int; 2007 Jun; 57(6):343-50. PubMed ID: 17539965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bullous poikilodermatitic amyloidosis of the skin with junctional bulla development in IgG light chain plasmacytoma of the lambda type. Histology, immunohistology and electron microscopy].
    Winzer M; Ruppert M; Baretton G; Quast U; Wolff HH
    Hautarzt; 1992 Apr; 43(4):199-204. PubMed ID: 1597368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-lambda-light chain-peptide antibodies are suitable for the immunohistochemical classification of AL amyloid.
    Kuçi H; Ebert MP; Röcken C
    Histol Histopathol; 2007 Apr; 22(4):379-87. PubMed ID: 17290348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.